EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 151 filers reported holding EPIZYME INC in Q3 2020. The put-call ratio across all filers is 2.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,368,000 | +154.3% | 930,718 | +98.9% | 0.20% | +184.7% |
| Q1 2022 | $538,000 | +73.0% | 467,836 | +275.8% | 0.07% | +84.6% |
| Q4 2021 | $311,000 | -15.3% | 124,500 | +73.8% | 0.04% | +5.4% |
| Q3 2021 | $367,000 | -34.3% | 71,652 | +11.7% | 0.04% | -60.2% |
| Q1 2021 | $559,000 | -41.1% | 64,143 | -19.4% | 0.09% | -41.1% |
| Q3 2020 | $949,000 | +209.1% | 79,582 | +221.6% | 0.16% | +409.7% |
| Q1 2019 | $307,000 | +16.7% | 24,742 | -42.1% | 0.03% | +3.3% |
| Q4 2018 | $263,000 | -30.2% | 42,766 | +94.4% | 0.03% | +50.0% |
| Q1 2017 | $377,000 | -1.3% | 22,000 | -43.4% | 0.02% | -4.8% |
| Q3 2016 | $382,000 | – | 38,860 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |